| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bc408585f6863d7865c90ab9a4632135 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-52 |
| filingDate |
2003-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ad135bcba5444b340b4f53f4318915c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19ee969747e24902c5f9f5113c4f53a3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_267f6cf4fc640e7b252f68dd0799b9d8 |
| publicationDate |
2004-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2004012664-A2 |
| titleOfInvention |
Administration of estradiol metabolites for inhibition of drug-induced nephrotoxicity |
| abstract |
Methods and composition are provided for the treatment or prevention of drug-induced nephrotoxicity and related conditions. More particularly, this invention relates to compositions comprising estradiol metabolites, and prodrugs thereof, that may be incorporated in various controlled release formulations. |
| priorityDate |
2002-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |